U.S. Scientists Propose Using Brain-Dead Patients for Medical Research

The Centers for Disease Control and Prevention (CDC) reported a dramatic 27% decrease in U.S. drug overdose deaths for 2024, with approximately 80,000 fatalities compared to 110,000 in 2023. This represents the largest one-year decline in recorded history. Almost all states saw reductions, except for Nevada and South Dakota, which experienced slight increases.
Experts attribute the decrease to multiple factors, including improved access to naloxone, expanded addiction treatment options, and shifts in drug usage trends. Furthermore, significant settlements from opioid manufacturers, promising about $50 billion to combat addiction issues, have contributed to increasing resources for prevention and treatment programs. Despite these improvements, overdose deaths remain higher than pre-COVID levels, with the CDC noting that such incidents continue to be the leading cause of death among individuals aged 18 to 44.
Public health advocates caution that decreased federal funding and support could reverse this trend. Experts emphasize that sustained effort and resources are needed to combat the ongoing crisis effectively.